General market situation:
Markets resume standard trading after the Easter break. US stock index futures are trading higher. However, we are seeing a slightly different mood in Europe, as the declines observed yesterday on Wall Street are taking hold here. The German DAX is currently losing 0.71%, while the French CAC40 is down 0.73%.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe most important events of the day will be the quarterly results of Tesla and SAP. Macroeconomic data from the Polish labor market, numerous speeches by FED and ECB bankers (including Lagarde) and the industrial price index from Canada.
Distribution of today's returns of companies from Europe. Source: xStation
The German DE40 index is losing 0.47% today on an intraday basis. The contract is holding around the 100-day EMA (purple line) and the local highs from April 9 and 10, which are a point of technical resistance. Source: xStation
News:
Novo Nordisk (NOVOB.DK) shares fell Tuesday after Eli Lilly (LLY.US) reported results for a new pill that could match the weight-loss potential of the Danish giant’s blockbuster injections. Novo Nordisk and Eli Lilly currently dominate the weight-loss market, but their drugs are administered as injections. Both companies are working on pill versions that are said to be more convenient for patients, as well as easier to transport and store because they don’t require refrigeration. Lilly’s drug helped patients lose an average of 7.9% of their body weight at the highest dose. Novo Nordisk shares fell as much as 9.8% in early European trading.
Source: xStation
L’Oreal (OR.FR) shares are up 3.6% after the cosmetics maker’s comparable sales growth beat analysts’ expectations. Investors were also quieted by relatively positive comments from the company’s CEO. The CEO expects sales and profit growth in the fiscal year.
Q1 RESULTS
- Like-for-like sales +3.5%, estimated +1.26%
- Consumer products like-for-like sales +2.3%, estimated +1.44%
- North America like-for-like sales -3.8%, estimated -0.64%
- North Asia like-for-like sales +6.9%, estimated -3.01%
- Europe like-for-like sales +4.3%, estimated +2.53%
- South Asia Pacific, Middle East, North Africa and Sub-Saharan Africa like-for-like sales +10.4%, estimated +8.45%
- Latin America like-for-like sales +7.9%, estimated +6.77%
- Currency impact +0.4%
- Sales €11.73bn, +4.4% y/y, estimated €11.45bn
More news from German companies. Source: Bloomberg Financial LP
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
